Edward W Boyer Selected Research

Edward W Boyer Research Topics

Disease

12	Opioid-Related Disorders (Opiate Addiction) 01/2023 - 10/2006
8	Pain (Aches) 01/2023 - 01/2017
7	COVID-19 01/2022 - 04/2020
6	Acute Pain 01/2023 - 01/2016
6	Poisoning 01/2018 - 02/2002
5	Substance-Related Disorders (Drug Abuse) 01/2016 - 12/2004
4	Opiate Overdose 01/2022 - 01/2018
3	Neoplasms (Cancer) 01/2023 - 01/2019
3	Infections 01/2021 - 08/2014
3	Chronic Pain 01/2010 - 09/2007
2	Wounds and Injuries (Trauma) 01/2019 - 01/2018
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 07/2009 - 02/2008
2	Hyperinsulinism (Hyperinsulinemia) 09/2007 - 02/2002
2	Respiratory Insufficiency (Respiratory Failure) 10/2006 - 12/2003
1	Burns 01/2023
1	Anosmia 06/2020
1	Olfaction Disorders (Cacosmia) 06/2020
1	Pneumothorax 03/2020
1	Postpartum Hemorrhage 05/2019
1	Fatigue 01/2019
1	Cytokine Release Syndrome 01/2019
1	B-Cell Leukemia (Leukemia, B Cell) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Hepatitis B 12/2018
1	Weight Loss (Weight Reduction) 08/2017
1	Hypotension (Low Blood Pressure) 08/2017
1	Dehydration (Water Stress) 01/2017
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2017
1	Nausea 01/2017
1	Diabetes Mellitus 01/2017
1	Vomiting 01/2017
1	Ketosis 01/2017
1	Acidosis 01/2017
1	Psychotic Disorders (Schizoaffective Disorder) 07/2016
1	Soft Tissue Infections 12/2015
1	Apnea 10/2014
1	Diarrhea 10/2014
1	Clostridium Infections 10/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2014
1	Human Influenza (Influenza) 08/2014
1	Status Epilepticus (Complex Partial Status Epilepticus) 05/2013

Drug/Important Bio-Agent (IBA)

21	Opioid Analgesics (Opioids)IBA 01/2023 - 09/2007
3	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 10/2014
3	Buprenorphine (Subutex)FDA LinkGeneric 12/2018 - 10/2006
3	Naloxone (Narcan)FDA LinkGeneric 01/2018 - 10/2014
3	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2013 - 12/2004
2	AntibodiesIBA 01/2021 - 08/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2019
2	mitragynineIBA 01/2019 - 02/2008
2	Methadone (Dolophine)FDA LinkGeneric 12/2018 - 01/2010
2	Narcotics (Narcotic Analgesics)IBA 06/2012 - 02/2008
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2007 - 02/2002
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022
1	Hydrocodone (Dihydrocodeinone)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	TeaIBA 11/2020
1	Therapeutic UsesIBA 11/2020
1	Odorant Receptors (Odorant Receptor)IBA 06/2020
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	CarcinogensIBA 01/2019
1	Rilpivirine (TMC-278)IBA 01/2019
1	Emtricitabine (Emtriva)FDA Link 01/2019
1	tocilizumab (atlizumab)FDA Link 01/2019
1	altersolanol AIBA 01/2019
1	Chimeric Antigen ReceptorsIBA 01/2019
1	Methylene Chloride (Dichloromethane)IBA 01/2019
1	AlkaloidsIBA 01/2019
1	AntidotesIBA 01/2018
1	novichokIBA 01/2018
1	Nerve AgentsIBA 01/2018
1	Morphine (MS Contin)FDA LinkGeneric 12/2017
1	esmolol (Brevibloc)FDA LinkGeneric 08/2017
1	ClenbuterolIBA 08/2017
1	CanagliflozinIBA 01/2017
1	antineoplaston A10 (A 10)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	CannabinoidsIBA 07/2016
1	Fentanyl (Sublimaze)FDA LinkGeneric 10/2014
1	AntigensIBA 08/2014
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 09/2013
1	hydroquinone (Esoterica)FDA Link 05/2013
1	SolutionsIBA 05/2013
1	Codeine (Codeine Phosphate)FDA LinkGeneric 01/2013

Therapy/Procedure

11	Therapeutics 01/2023 - 02/2002
3	Personal Protective Equipment 01/2022 - 04/2020
2	Drug Therapy (Chemotherapy) 12/2018 - 12/2011
1	Continuity of Patient Care 01/2023
1	Meditation 12/2021
1	Polypharmacy 09/2021
1	Catheters 01/2021
1	Thoracostomy 03/2020
1	Anesthesia 05/2019
1	Immunotherapy 01/2019
1	Smart Glasses 01/2018
1	Music Therapy 09/2017
1	Resuscitation 01/2017
1	Pain Management 01/2016
1	Aftercare (After-Treatment) 12/2015